Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1144-1148, March 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, X.
Right arrow Articles by Bigner, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, X.
Right arrow Articles by Bigner, D. D.

Expression of O6-Methylguanine-DNA Methyltransferase in Six Human Medulloblastoma Cell Lines1

Xuanmin He, Lawrence E. Ostrowski, Mathew A. von Wronski, Henry S. Friedman, Carol J. Wikstrand, Sandra H. Bigner, Ahmed Rasheed, Surinder K. Batra, Sankar Mitra, Thomas P. Brent and Darell D. Bigner2

Departments of Pathology [X. H., L. E. O., H. S. F., C. J. W., S. H. B., A. R., S. K. B., D. D. B.] and Pediatrics [H. S. F.] and the Pressu Laboratory for Brain Tumor Research [D. D. B.], Duke University Medical Center, Durham, North Carolina 27710; Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101 [M. A. v. W., T. P. B.]; and University of Tennessee Graduate School of Biomedical Sciences and Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831 [S. M.]

Six well characterized human medulloblastoma cell lines (D283 Med, Daoy, D341 Med, D384 Med, D425 Med, and D458 Med) were examined for the expression of O6-methylguanine-DNA methyltransferase (MGMT) by activity and Western and Northern blot analysis. High levels of MGMT activity were present in D283 Med, Daoy, D341 Med, and D384 Med (1.36, 0.80, 1.68, and 1.62 pmol/mg of protein, respectively), but negligible MGMT activity was detected in D425 Med and D458 Med (0.06 and 0.05 pmol/mg of protein, respectively), which were derived separately at different times from the same patient. The presence of MGMT protein and its transcript was demonstrated in D283 Med, Daoy, D341 Med, and D384 Med, but both the protein and the mRNA were undetectable in D425 Med and D458 Med. Nevertheless, all six cell lines contained an apparently unaltered MGMT gene, as determined by Southern blot analysis. The absence of MGMT activity in D425 Med and D458 Med is likely due to the absence of the protein, resulting from a lack of transcription of the MGMT gene. The varying levels of expression of MGMT in medulloblastoma cells found in this study should provide a molecular basis for drug design and selection in chemotherapy of this tumor.

1 This work was supported by NIH Grants CA 11898, CA 32672, NS 20023, CA 44640, CA 31721, CA 14799, CA 36888, and CA 23099, American Cancer Society Grant CH 403B, and Bristol-Myers Research Grant 100-R18, by the United States Department of Energy under contract DEACO5-840R21400 with Martin Marietta Energy Systems, Inc., and by the American Lebanese Syrian Associated Charities. M. A. v. W. is a recipient of NIH Postdoctoral Fellowship CA 09346.

2 To whom requests for reprints should be addressed, at P. O. Box 3156, Department of Pathology, Duke University Medical Center, Durham, NC 27710.

Received 4/ 3/91. Accepted 12/16/91.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
J. A. Maxwell, S. P. Johnson, J. A. Quinn, R. E. McLendon, F. Ali-Osman, A. H. Friedman, J. E. Herndon II, K. Bierau, J. Bigley, D. D. Bigner, et al.
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.
Mol. Cancer Ther., October 1, 2006; 5(10): 2531 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X.-N. Li, Q. Shu, J. M.-F. Su, L. Perlaky, S. M. Blaney, and C. C. Lau
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
Mol. Cancer Ther., December 1, 2005; 4(12): 1912 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
B. R. Rood, H. Zhang, and P. H. Cogen
Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma
Neuro-oncol, July 1, 2004; 6(3): 200 - 207.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
X.-N. Li, S. Parikh, Q. Shu, H.-L. Jung, C.-W. Chow, L. Perlaky, H.-C. E. Leung, J. Su, S. Blaney, and C. C. Lau
Phenylbutyrate and Phenylacetate Induce Differentiation and Inhibit Proliferation of Human Medulloblastoma Cells
Clin. Cancer Res., February 1, 2004; 10(3): 1150 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Y. Chen, L. C. Harris, J. S. Remack, and T. P. Brent
Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells
PNAS, April 29, 1997; 94(9): 4348 - 4353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.